Consolis

Consolis

Design and manufacturing of high performance concrete products

Cisbio operates mostly in Life Sciences Drug Discovery. It also has a small In-Vitro Diagnostics business unit. It serves clients through both a direct sales organization and distributors. It has 3 overseas subsidiaries (USA, China, Japan). Life Sciences activities serve big pharmas as well as biotechs and university research institutes. They focus on developing reagents at early phases of the biopharma R&D value chain, when biotechs/pharmas perform series of key tests to bring therapeutic candidates to clinical trials. The group IVD activities manufacture reagents to perform tests on biological samples (e.g.: blood, urine, tissues) to diagnose diseases in medical laboratories.

Data di prima partecipazione

October 2005

Tipo di contratto

2nd LMBO

Fatturato

1196m€

Numero di dipendenti

9758

Data di vendita

March 2007

Tipo di vendita

Secondary LBO to LBO France